{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:31:41Z","timestamp":1775244701332,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.acvd.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:15:24Z","timestamp":1739492124000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Percutaneous coronary intervention in patients with acute coronary syndromes and increased platelet count"],"prefix":"10.1016","volume":"118","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-8093","authenticated-orcid":false,"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-3128","authenticated-orcid":false,"given":"Louise","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7493-1527","authenticated-orcid":false,"given":"Yiqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-3449","authenticated-orcid":false,"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-0799","authenticated-orcid":false,"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2025.01.005_bib0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","article-title":"Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease","volume":"356","author":"Wallentin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2025.01.005_bib0215","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0220","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","article-title":"Acute coronary syndromes","volume":"399","author":"Bergmark","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2025.01.005_bib0225","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ahj.2009.09.008","article-title":"Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: results from the CRUSADE quality improvement initiative","volume":"158","author":"Amsterdam","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.05.015","article-title":"Contemporary invasive management and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction in China: findings from China Acute Myocardial Infarction (CAMI) Registry","volume":"215","author":"Leng","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0235","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jcin.2012.07.012","article-title":"Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes","volume":"5","author":"Dangas","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2025.01.005_bib0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41569-018-0118-5","article-title":"Predictors of stent thrombosis and their implications for clinical practice","volume":"16","author":"Gori","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2025.01.005_bib0245","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2012-04-424911","article-title":"Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort","volume":"120","author":"Campbell","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.acvd.2025.01.005_bib0250","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2025.01.005_bib0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ahj.2016.06.005","article-title":"Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: a national effort to prompt quality enhancement for acute coronary syndrome","volume":"179","author":"Hao","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0260","first-page":"675","article-title":"[Guideline for diagnosis and treatment of patients with ST-elevation myocardial infarction]","volume":"38","author":"Editorial Board of Chinese Journal of Cardiology","year":"2010","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.acvd.2025.01.005_bib0265","first-page":"353","article-title":"[Guideline of non-ST segment elevation acute coronary syndrome]","volume":"40","author":"Editorial Board of Chinese Journal of Cardiology","year":"2012","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.acvd.2025.01.005_bib0270","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/09537104.2020.1769052","article-title":"Platelet count and risk of major bleeding in venous thromboembolism","volume":"32","author":"Johnsen","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.acvd.2025.01.005_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2006.01.046","article-title":"Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials)","volume":"98","author":"Ly","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2025.01.005_bib0280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0285","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0290","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2025.01.005_bib0295","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2025.01.005_bib0300","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2025.01.005_bib0305","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.acvd.2025.01.005_bib0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcin.2017.07.022","article-title":"Multisite investigation of outcomes with implementation of CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention","volume":"11","author":"Cavallari","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2025.01.005_bib0315","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/2048872620925257","article-title":"Association of baseline platelet count with all-cause mortality after acute myocardial infarction","volume":"10","author":"Song","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.acvd.2025.01.005_bib0320","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/2048872616643690","article-title":"Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention","volume":"6","author":"Sharif","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.acvd.2025.01.005_bib0325","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.amjcard.2006.11.066","article-title":"Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)","volume":"99","author":"Nikolsky","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2025.01.005_bib0330","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jccase.2013.08.001","article-title":"Therapeutic dilemmas in the treatment of acute coronary syndrome as manifestation of essential thrombocythaemia","volume":"8","author":"Bo\u0161njak","year":"2013","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.acvd.2025.01.005_bib0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11239-017-1490-4","article-title":"Essential thrombocythemia presenting as acute coronary syndrome: case reports and literature review","volume":"44","author":"Xiong","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acvd.2025.01.005_bib0340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2016.11.011","article-title":"Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera","volume":"41","author":"Rottenstreich","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.acvd.2025.01.005_bib0345","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.acvd.2025.01.005_bib0350","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.acvd.2025.01.005_bib0355","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0360","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.acvd.2024.02.012","article-title":"Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: proposed management algorithm for the first 48\u00a0hours","volume":"117","author":"Salaun","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2025.01.005_bib0365","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/jcm9103370","article-title":"Ischemic and bleeding events associated with thrombocytopenia and thrombocytosis after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"9","author":"Roh","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.acvd.2025.01.005_bib0370","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1253\/circj.CJ-11-0707","article-title":"Baseline platelet count and clinical outcome in acute coronary syndrome","volume":"76","author":"Wu","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0375","first-page":"346","article-title":"Association between baseline platelet count and severe adverse outcomes following percutaneous coronary intervention","volume":"15","author":"Cheng","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.acvd.2025.01.005_bib0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2025.01.005_bib0385","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.01.005_bib0390","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2025.01.005_bib0395","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2025.01.005_bib0400","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2025.01.005_bib0405","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa2307770","article-title":"OCT or angiography guidance for PCI in complex bifurcation lesions","volume":"389","author":"Holm","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2025.01.005_bib0410","doi-asserted-by":"crossref","first-page":"e077848","DOI":"10.1136\/bmj-2023-077848","article-title":"Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis","volume":"383","author":"Khan","year":"2023","journal-title":"BMJ"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213625000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213625000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:45:18Z","timestamp":1746729918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213625000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1875213625000531"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2025.01.005","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous coronary intervention in patients with acute coronary syndromes and increased platelet count","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}